---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-118126"
form_type: "8-K"
ticker: "OCUL"
cik: "0001393434"
company_name: "OCULAR THERAPEUTIX, INC"
filed_at: "2021-09-22T23:59:59+00:00"
generated_at: "2026-06-29T02:01:24.057265+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Ocular Therapeutix elects Merilee Raines to Board of Directors

## Summary
- Merilee Raines elected to the Board as Class III director effective September 20, 2021.
- She will serve on the Audit Committee and her term expires at the 2023 annual meeting.
- Raines received an option to purchase 36,000 shares at $10.02 per share upon election.
- She previously served as CFO of IDEXX Laboratories from 2003 to 2013.

## SEC filing metadata
- accession: 0001104659-21-118126
- form_type: 8-K
- ticker: OCUL
- cik: 0001393434
- company_name: OCULAR THERAPEUTIX, INC
- filed_at: 2021-09-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1393434/000110465921118126/0001104659-21-118126-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1393434/000110465921118126/tm2128101d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-118126
- JSON: https://secwatch.observer/filing/0001104659-21-118126.json
- Plain text: https://secwatch.observer/filing/0001104659-21-118126.txt

## Key facts
- Executive change
  Merilee Raines was elected as Director at OCULAR THERAPEUTIX, INC.
  - Action: elected
  - Role: Director
  source text: elected Merilee Raines to serve as a member of the Board to fill a vacancy on the Board
  evidence_url: https://www.sec.gov/Archives/edgar/data/1393434/000110465921118126/0001104659-21-118126-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.